Dongfang Jiafu logo

Dongfang Jiafu

Asia, Zhejiang, China, Hangzhou

Description

Dongfang Jiafu is an equity fund management firm.

Investor Profile

Dongfang Jiafu has made 5 investments, with 3 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (60%)
  • Series C (20%)
  • Post Ipo Equity (20%)

Country Focus

  • China (100%)

Industry Focus

  • Automotive
  • Autonomous Vehicles
  • Electronics
  • Enterprise
  • Manufacturing
  • Biopharma
  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Consumer
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Dongfang Jiafu frequently co-invest with?

Co-Investments: 1
Puhua Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
Conswall Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
HK
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Haibang Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
Co-Investments: 1
HT Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Haitong Capital
Europe, Lisboa, Portugal, Lisbon
Co-Investments: 2

What are some of recent deals done by Dongfang Jiafu?

Sanyou Medical

Shanghai, Shanghai, China

Sanyou Medical is a corporation that is therapy innovation oriented and devotes to the R&D.

Innovation ManagementMedicalMedical DeviceTherapeutics
Post Ipo EquityMar 13, 2025
Amount Raised: $29,566,791
Bibost Automotive Electronics

Fengtai, Beijing, China

Bibost Automotive Electronics is a provider of automotive electronic products.

AutomotiveAutonomous VehiclesElectronicsEnterpriseManufacturing
Series BJan 9, 2025
Amount Raised: $40,921,553
Torrance Precision

Huilong, Jiangsu, China

Torrance Precision is an industrial company that provides CNC machining, system assembly, and welding processing solutions.

IndustrialIndustrial EngineeringSemiconductor
Series CDec 3, 2024
Healsun Biopharm

Hangzhou, Zhejiang, China

Healsun Biopharm is a Biopharmaceutical company that focuses on antibody/recombinant protein CRO/CDMO

BiopharmaBiotechnologyHealth CarePharmaceutical
Series BAug 19, 2022
Amount Raised: $36,672,485
Jiangrongxin Technology

Beijing, Beijing, China

Jiangrongxin Technology is a Developer of financial and marketing software for consumer financial services enterprises.

ConsumerFinancial ServicesInformation TechnologyMarketingSoftware
Series BAug 5, 2019
Amount Raised: $42,549,570